What is the recommended dose of Adderall (amphetamine and dextroamphetamine) when switching from 40 mg of Vyvanse (lisdexamfetamine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Dose Conversion from Vyvanse to Adderall

When switching from 40 mg of Vyvanse to Adderall in a patient in their 20s, start with 10-15 mg of Adderall (not 20 mg), as lisdexamfetamine is converted to dextroamphetamine at approximately a 1:0.3 ratio, making 40 mg of Vyvanse roughly equivalent to 12 mg of dextroamphetamine base. 1, 2

Understanding the Conversion Ratio

  • Lisdexamfetamine (Vyvanse) is a prodrug that is converted to dextroamphetamine after ingestion, with the conversion occurring through enzymatic hydrolysis 1, 3

  • The molecular weight difference means that 40 mg of lisdexamfetamine yields approximately 12 mg of active dextroamphetamine 2

  • Adderall contains a 3:1 ratio of dextroamphetamine to levoamphetamine salts, so the dextroamphetamine component is approximately 75% of the total dose 4

Recommended Starting Approach

Start with 10 mg of Adderall (either immediate-release twice daily as 5 mg doses, or extended-release once daily), then titrate upward in 5-10 mg increments weekly based on symptom control. 4, 5

  • For adults, the American Academy of Child and Adolescent Psychiatry recommends starting at 5 mg of immediate-release amphetamine formulations with titration upward in 5-10 mg intervals each week until symptoms are controlled 4

  • The maximum daily dose for adults is generally 40 mg for mixed amphetamine salts, though some patients may require up to 50 mg with clear documentation of need 4, 5

Why 20 mg May Be Too High Initially

  • Starting at 20 mg represents a significant jump from the equivalent of 12 mg dextroamphetamine base from the 40 mg Vyvanse dose 2

  • The pharmacokinetic profile shows that equimolar doses of lisdexamfetamine and D-amphetamine produce similar peak concentrations and total exposure, but the immediate-release nature of Adderall IR may produce more pronounced peak effects 2

  • A more conservative starting dose minimizes the risk of cardiovascular side effects (increased blood pressure and heart rate) and other adverse effects like agitation or insomnia 4, 2

Titration Strategy

  • Begin with 10 mg daily (either as 5 mg twice daily for IR or 10 mg once daily for XR formulation) 4, 5

  • Increase by 5-10 mg weekly based on clinical response, monitoring with standardized ADHD rating scales when possible 4

  • Monitor blood pressure and pulse quarterly in adults on stimulants 5

  • If 10-15 mg proves insufficient after 1-2 weeks, then consider increasing to 20 mg, but this should be based on documented inadequate response rather than assumed equivalence 4

Important Caveats

  • The patient's ability to communicate symptoms does not justify skipping conservative dose titration, as cardiovascular and psychiatric side effects can occur even in articulate patients 4, 2

  • Document clearly if higher doses (approaching 40-50 mg) are needed, noting that symptoms could not be controlled at lower doses and that higher doses are not producing side effects 4

  • Consider that approximately 70% of patients respond to a single stimulant, and if inadequate response occurs at maximum doses, switching to an alternative stimulant may be more appropriate than exceeding recommended maximums 4, 5

References

Guideline

Placental Transfer of Vyvanse

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Maximum Recommended Doses of Adderall XR and IR for ADHD

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.